Stroke prevention based on the Stroke Treatment Guideline 2021

Abstract

Stroke prevention constitutes antithrombotic treatments and risk control. Atherothrombosis may be treated with dual platelet therapy in the acute phase followed by single therapy with additional cilostazol in high risk group. Cardioembolism and paradoxical embolism should be treated with anticoagulants. Direct oral anticoagulants with dose based on age, renal function and body weight has fewer intracranial hemorrhages than warfarin and is recommended as first choice.